Table 5.
Number and Percentage Adherent to HAART Medication According to Quartiles of the Self-Efficacy and Outcome Expectancy Distribution
| |
OE quartile |
|
|||
|---|---|---|---|---|---|
| SE quartiles |
Low (Q1) n (%) |
Q2 n (%) |
Q3 n (%) |
High (Q4) n (%) |
Total n (%) |
| Low (Q1) | 10 (22.2) | 6 (23.1) | 6 (40.0) | 5 (45.5) | 27 (27.8) |
| Q2 | 8 (47.1) | 14 (53.8) | 18 (50.0) | 11 (52.4) | 51 (51.0) |
| Q3 | 3 (30.0) | 24 (85.7) | 16 (72.7) | 27 (87.1) | 70 (76.9) |
| High (Q4) | 7 (87.5) | 15 (78.9) | 30 (96.8) | 48 (96.0) | 100 (92.6) |
| Total | 28 (35.0) | 59 (59.6) | 70 (67.3) | 91 (80.5) | 248 (62.6) |
SE, self-efficacy; OE, outcome expectancy; HAART, highly active antiretroviral therapy.